CDRE
Cadre Holdings, Inc.
Aerospace & Defense
Market Cap$1.26B
5Y Perf.+47.5%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
CDRE vs HON
Revenue, margins, valuation, and 5-year total return — side by side.
HON
Honeywell International Inc.
Conglomerates
Market Cap$136.91B
5Y Perf.+6.8%
CDRE vs HON — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CDRE | HON |
|---|---|---|
| Industry | Aerospace & Defense | Conglomerates |
| Market Cap | $1.26B | $136.91B |
| Revenue (TTM) | $610M | $36.76B |
| Net Income (TTM) | $44M | $4.10B |
| Gross Margin | 42.5% | 36.9% |
| Operating Margin | 12.3% | 14.9% |
| Forward P/E | 23.8x | 20.5x |
| Total Debt | $322M | $34.58B |
| Cash & Equiv. | $123M | $12.49B |
CDRE vs HON — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CDRE
HON
| Stock | Nov 21 | May 26 | Return |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | 100 | 147.5 | +47.5% |
| Honeywell Internati… (HON) | 100 | 106.8 | +6.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CDRE vs HON
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: HON leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Cadre Holdings, Inc. is the stronger pick specifically for operational efficiency and capital deployment. As sector peers, any of these can serve as alternatives in the same allocation.
CDRE
Cadre Holdings, Inc.
The Growth Play
CDRE is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 7.5%, EPS growth 13.3%, 3Y rev CAGR 10.1%
- Lower volatility, beta 1.48, current ratio 3.50x
- 5.9% ROA vs HON's 5.3%, ROIC 11.9% vs 12.6%
Best for: growth exposure and sleep-well-at-night
HON
Honeywell International Inc.
The Income Pick
HON carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- 135.1% 10Y total return vs CDRE's 106.3%
- Beta 0.74, yield 2.1%, current ratio 1.32x
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | HON | 7.8% revenue growth vs CDRE's 7.5% |
| Value | HON | Lower P/E (20.5x vs 23.8x) |
| Quality / Margins | HON | 11.2% margin vs CDRE's 7.2% |
| Stability / Safety | HON | Beta 0.74 vs CDRE's 1.48 |
| Dividends | HON | 2.1% yield, 15-year raise streak, vs CDRE's 1.2% |
| Momentum (1Y) | HON | +2.8% vs CDRE's -14.5% |
| Efficiency (ROA) | CDRE | 5.9% ROA vs HON's 5.3%, ROIC 11.9% vs 12.6% |
CDRE vs HON — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
CDRE vs HON — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLCDRELAGGINGHON
HONHoneywell Internation…
2leads
CDRECadre Holdings, Inc.
2leads
6 Total Categories
CATEGORYLEADERvs HONMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
Tied
—
Valuation MetricsMultiples, price ratios, and targets
CDRE5/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
CDRE5/9
Total Returns1Y, 3Y, 5Y total returns with dividends
Tied
—
Risk & VolatilityBeta, volatility, and downside exposure
HON2/2
Analyst OutlookRatings, price targets, and dividends
HON2/2
Income & Cash Flow (Last 12 Months)
Evenly matched — CDRE and HON each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 60.2x CDRE's $610M. Profitability is closely matched — net margins range from 11.2% (HON) to 7.2% (CDRE).
| Metric | CDRECadre Holdings, I… | HONHoneywell Interna… |
|---|---|---|
| RevenueTrailing 12 months | $610M | $36.8B |
| EBITDAEarnings before interest/tax | $94M | $6.5B |
| Net IncomeAfter-tax profit | $44M | $4.1B |
| Free Cash FlowCash after capex | $57M | $4.2B |
| Gross MarginGross profit ÷ Revenue | +42.5% | +36.9% |
| Operating MarginEBIT ÷ Revenue | +12.3% | +14.9% |
| Net MarginNet income ÷ Revenue | +7.2% | +11.2% |
| FCF MarginFCF ÷ Revenue | +9.3% | +11.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -5.0% | -6.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -15.6% | -41.9% |
Evenly matched — CDRE and HON each lead in 3 of 6 comparable metrics.
Valuation Metrics
CDRE leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 29.3x trailing earnings, CDRE trades at a 0% valuation discount to HON's 29.4x P/E. On an enterprise value basis, CDRE's 15.5x EV/EBITDA is more attractive than HON's 20.0x.
| Metric | CDRECadre Holdings, I… | HONHoneywell Interna… |
|---|---|---|
| Market CapShares × price | $1.3B | $136.9B |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $159.0B |
| Trailing P/EPrice ÷ TTM EPS | 29.30x | 29.36x |
| Forward P/EPrice ÷ next-FY EPS est. | 23.76x | 20.52x |
| PEG RatioP/E ÷ EPS growth rate | — | 15.99x |
| EV / EBITDAEnterprise value multiple | 15.53x | 19.99x |
| Price / SalesMarket cap ÷ Revenue | 2.06x | 3.66x |
| Price / BookPrice ÷ Book value/share | 4.08x | 9.00x |
| Price / FCFMarket cap ÷ FCF | 22.17x | 25.39x |
CDRE leads this category, winning 5 of 6 comparable metrics.
Profitability & Efficiency
CDRE leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
HON delivers a 23.1% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $13 for CDRE. CDRE carries lower financial leverage with a 1.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), HON scores 6/9 vs CDRE's 5/9, reflecting solid financial health.
| Metric | CDRECadre Holdings, I… | HONHoneywell Interna… |
|---|---|---|
| ROE (TTM)Return on equity | +13.5% | +23.1% |
| ROA (TTM)Return on assets | +5.9% | +5.3% |
| ROICReturn on invested capital | +11.9% | +12.6% |
| ROCEReturn on capital employed | +12.3% | +12.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 1.01x | 2.24x |
| Net DebtTotal debt minus cash | $199M | $22.1B |
| Cash & Equiv.Liquid assets | $123M | $12.5B |
| Total DebtShort + long-term debt | $322M | $34.6B |
| Interest CoverageEBIT ÷ Interest expense | 6.34x | 3.92x |
CDRE leads this category, winning 5 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
Evenly matched — CDRE and HON each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CDRE five years ago would be worth $20,628 today (with dividends reinvested), compared to $10,326 for HON. Over the past 12 months, HON leads with a +2.8% total return vs CDRE's -14.5%. The 3-year compound annual growth rate (CAGR) favors CDRE at 14.3% vs HON's 5.1% — a key indicator of consistent wealth creation.
| Metric | CDRECadre Holdings, I… | HONHoneywell Interna… |
|---|---|---|
| YTD ReturnYear-to-date | -26.8% | +10.9% |
| 1-Year ReturnPast 12 months | -14.5% | +2.8% |
| 3-Year ReturnCumulative with dividends | +49.3% | +16.2% |
| 5-Year ReturnCumulative with dividends | +106.3% | +3.3% |
| 10-Year ReturnCumulative with dividends | +106.3% | +135.1% |
| CAGR (3Y)Annualised 3-year return | +14.3% | +5.1% |
Evenly matched — CDRE and HON each lead in 3 of 6 comparable metrics.
Risk & Volatility
HON leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than CDRE's 1.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HON currently trades 87.1% from its 52-week high vs CDRE's 61.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CDRECadre Holdings, I… | HONHoneywell Interna… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.48x | 0.74x |
| 52-Week HighHighest price in past year | $48.76 | $248.18 |
| 52-Week LowLowest price in past year | $27.33 | $186.76 |
| % of 52W HighCurrent price vs 52-week peak | +61.3% | +87.1% |
| RSI (14)Momentum oscillator 0–100 | 48.8 | 45.1 |
| Avg Volume (50D)Average daily shares traded | 417K | 3.7M |
HON leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
HON leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates CDRE as "Buy" and HON as "Buy". Consensus price targets imply 72.3% upside for CDRE (target: $52) vs 12.8% for HON (target: $244). For income investors, HON offers the higher dividend yield at 2.14% vs CDRE's 1.19%.
| Metric | CDRECadre Holdings, I… | HONHoneywell Interna… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $51.50 | $243.83 |
| # AnalystsCovering analysts | 9 | 28 |
| Dividend YieldAnnual dividend ÷ price | +1.2% | +2.1% |
| Dividend StreakConsecutive years of raises | 2 | 15 |
| Dividend / ShareAnnual DPS | $0.36 | $4.63 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.8% |
HON leads this category, winning 2 of 2 comparable metrics.
Key Takeaway
CDRE leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). HON leads in 2 (Risk & Volatility, Analyst Outlook). 2 tied.
Best OverallCadre Holdings, Inc. (CDRE)Leads 2 of 6 categories
Loading custom metrics...
CDRE vs HON: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CDRE or HON a better buy right now?
For growth investors, Honeywell International Inc.
(HON) is the stronger pick with 7. 8% revenue growth year-over-year, versus 7. 5% for Cadre Holdings, Inc. (CDRE). Cadre Holdings, Inc. (CDRE) offers the better valuation at 29. 3x trailing P/E (23. 8x forward), making it the more compelling value choice. Analysts rate Cadre Holdings, Inc. (CDRE) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CDRE or HON?
On trailing P/E, Cadre Holdings, Inc.
(CDRE) is the cheapest at 29. 3x versus Honeywell International Inc. at 29. 4x. On forward P/E, Honeywell International Inc. is actually cheaper at 20. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CDRE or HON?
Over the past 5 years, Cadre Holdings, Inc.
(CDRE) delivered a total return of +106. 3%, compared to +3. 3% for Honeywell International Inc. (HON). Over 10 years, the gap is even starker: HON returned +135. 1% versus CDRE's +106. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CDRE or HON?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Cadre Holdings, Inc. 's 1. 48β — meaning CDRE is approximately 99% more volatile than HON relative to the S&P 500. On balance sheet safety, Cadre Holdings, Inc. (CDRE) carries a lower debt/equity ratio of 101% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CDRE or HON?
By revenue growth (latest reported year), Honeywell International Inc.
(HON) is pulling ahead at 7. 8% versus 7. 5% for Cadre Holdings, Inc. (CDRE). On earnings-per-share growth, the picture is similar: Cadre Holdings, Inc. grew EPS 13. 3% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, CDRE leads at 10. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CDRE or HON?
Honeywell International Inc.
(HON) is the more profitable company, earning 12. 6% net margin versus 7. 2% for Cadre Holdings, Inc. — meaning it keeps 12. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HON leads at 17. 5% versus 12. 3% for CDRE. At the gross margin level — before operating expenses — CDRE leads at 42. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CDRE or HON more undervalued right now?
On forward earnings alone, Honeywell International Inc.
(HON) trades at 20. 5x forward P/E versus 23. 8x for Cadre Holdings, Inc. — 3. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CDRE: 72. 3% to $51. 50.
08Which pays a better dividend — CDRE or HON?
All stocks in this comparison pay dividends.
Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 1. 2% for Cadre Holdings, Inc. (CDRE).
09Is CDRE or HON better for a retirement portfolio?
For long-horizon retirement investors, Honeywell International Inc.
(HON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 2. 1% yield, +135. 1% 10Y return). Both have compounded well over 10 years (HON: +135. 1%, CDRE: +106. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CDRE and HON?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(CDRE: -5.0% · HON: -6.9%)Net Margin>
%
(CDRE: 7.2% · HON: 11.2%)P/E Ratio<
x
(CDRE: 29.3x · HON: 29.4x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.